Optimizing the Treatment Sequence From Second-Line to Third-Line Therapy in Patients With Metastatic Colorectal Cancer: Discussion

被引：0
|
作者：
Grothey, Axel
Prager, Gerald W.
Yoshino, Takayuki
Bekaii-Saab, Tanios S.
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2020年 / 18卷 / 01期
关键词：
GLIOBLASTOMA;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：21 / 23
页数：3
相关论文
共 50 条
  • [1] Optimizing Administration of Third-Line Treatment in Metastatic Colorectal Cancer
    Prager, Gerald W.
    Ducreux, Michel
    Argiles, Guillem
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (12) : 1 - 20
  • [2] Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer
    Ozaslan, Ersin
    Topaloglu, Ulas Serkan
    Inanc, Mevlude
    Erdem, Umut Gokmen
    Demir, Hacer
    Arpaci, Erkan
    Seker, Mehmet Metin
    Karaaga, Mustafa
    Kiziltepe, Melih
    Eker, Baki
    Ozkan, Metin
    JOURNAL OF BUON, 2017, 22 (04): : 863 - 868
  • [3] Is there a third-line therapy for metastatic colorectal cancer?
    Grothey, Axel
    SEMINARS IN ONCOLOGY, 2006, 33 (06) : S36 - S38
  • [4] Third-Line Therapy in Metastatic Colorectal Cancer
    van de Haar, Joris
    Valeri, Nicola
    Voest, Emile E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (02): : 190 - 191
  • [5] Third-line therapy for metastatic colorectal cancer
    M. G. Gundgaard
    J. B. Soerensen
    E. Ehrnrooth
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 1 - 13
  • [6] Third-line therapy for metastatic colorectal cancer
    Gundgaard, M. G.
    Soerensen, J. B.
    Ehrnrooth, E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (01) : 1 - 13
  • [7] Cabazitaxel as second-line or third-line therapy in patients with metastatic castration-resistant prostate cancer
    Kongsted, Per
    Svane, Inge M.
    Lindberg, Henriette
    Bisbjerg, Rasmus
    Daugaard, Gedske
    Sengelov, Lisa
    ANTI-CANCER DRUGS, 2016, 27 (07) : 695 - 701
  • [8] Current Options for Third-Line Treatment of Metastatic Colorectal Cancer: Discussion
    Grothey, Axel
    Marshall, John L.
    Seery, Tara E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) : 13 - 14
  • [9] A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer
    Cardin, Dana B.
    Thota, Ramya
    Goff, Laura W.
    Berlin, Jordan D.
    Jones, Clyde M.
    Ayers, Gregory D.
    Whisenant, Jennifer G.
    Chan, Emily
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (08): : 772 - 776
  • [10] Second-line treatment of patients with metastatic colorectal cancer
    Rougier, P
    Lepere, C
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S48 - S54
12345